{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fneurologypodcast.simplecast.com%2Fepisodes%2Fmanaging-td-an-overview-kdHNlJzu","width":444,"version":"1.0","type":"rich","title":"A Comprehensive Look at Tardive Dyskinesia Management","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/4131d070-81ff-4e87-980a-1ed1ed114456/pod474-sy-tardive-dyskinesia-podcast-teva-4.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2087a0a9-4187-4b2c-ba22-714ce5c052c7\" height=\"200\" width=\"100%\" title=\"A Comprehensive Look at Tardive Dyskinesia Management\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, Robert O. Cotes, MD, and Jonathan M. Meyer, MD, discuss tardive dyskinesia management from identification to follow-up, with a focus on VMAT2 inhibitors as a pharmacologic management strategy."}